Skip to main navigation Skip to search Skip to main content

NEO6860, modality-selective TRPV1 antagonist: A randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain

  • Pierre Arsenault
  • , Dan Chiche
  • , William Brown
  • , Jeffrey Miller
  • , Roi Treister
  • , Richard Leff
  • , Philippe Walker
  • , Nathaniel Katz

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'NEO6860, modality-selective TRPV1 antagonist: A randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science